Comparison of antinociceptive and antidiabetic effects of sertraline and amitriptyline on streptozotocin-induced diabetic rats

Abstract

Antidepressants (ADs) are frequently used for the treatment of persistent pain associated with diabetic neuropathy. The aim of this study is to investigate the antinociceptive effects of sertraline (Ser) and amitriptyline (Ami) in diabetic rats, and additionally monitoring their effects on grip strength, blood glucose and percentage glycosylated hemoglobin (GHb%) levels. Streptozotocin (STZ; 55 mg/kg, intraperitoneal [ip]) was injected in rats to induce diabetes. After 7 days, Ser (30 mg/kg) or Ami (15 mg/kg) was administered in diabetic rats orally. After 28 days drug treatment, the antinociceptive effects were evaluated using hot plate test both in diabetic and non-diabetic rats. The effects of these drugs on grip strength, blood glucose and GHb% were also measured. Ser and Ami showed antinociceptive effects in diabetic and non-diabetic rats. Both the drugs increased the grip strength reduction in STZ-induced diabetic rats. Ser reduces and Ami increases the serum glucose levels in diabetic and normal rats. Administration of Ami per se increased GHb% levels, while Ser per se has no effects. The effects of Ser (30 mg/kg, per os [po]) on glucose, GHb% and antinociceptive action on hot plate test showed an association between improved blood glucose levels and analgesia. However, the results of Ami treatment are controversial and needs further studies.

Keywords

neuropathy amitriptyline sertraline grip strength glycosylated hemoglobin

References

Douglas AG , Martin J. , Feldman L. Diabetic neuropathy: scope of the syndrome. Am J Med 1999; 107: 2S-8S.

Mark AR Neuropathies associated with diabetes. Med Clin North Am 1993; 27: 111-124.

Dejgaard A. Pathophysiology and treatment of diabetic neuropathy. Diab Med 1998; 15: 97-112.

McCarson KE , Ralya A. , Reisman SA , Enna SJ Amitriptyline prevents thermal hyperalgesia and modifications in rat spinal cord GABAB receptor expression and function in an animal model of neuropathic pain. Biochem Pharmacol 2005; 71: 196-202.

Vinik AI , Suwanwalaikorn S. , Stansberry KB , Holland MT , McNitt PM , Colen LE Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve 1995; 18: 574-584.

Ochoa JL Pain mechanism in neuropathy. Curr Opin Neurol 1994; 7: 407-414.

Boulton AJ , Malik RA , Arezzo JC , Sosenko JM Diabetic somatic neuropathies. Diabet Care 2004; 27: 1458-1486.

Hall GC , Carroll D. , Parry D. , McQuay HJ Epidemiology and treatment of neuropathic pain: the UK primary care perspective . Pain 2006; 122: 156-162.

Goodnick PJ , Jimenez I. , Kumar A. Sertraline in diabetic neuropathy: preliminary results. Ann Clin Psychiatr 1997; 9: 255-257.

10.

Goodnick PJ Use of antidepressant in the treatment of comorbid diabetes mellitus and depression as well as diabetic neuropathy. Ann Clin Psychiatr 2001; 13: 31-41.

11.

Fields HL , Heinricher MM , Mason P. Neurotransmitter in nociceptive modulatory circuits. Ann Rev Neurosci 1991; 14: 219-245.

12.

Ansari A. The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature. Harvard Rev Psychiatr 2000; 7: 257-277.

13.

Gupta B. , Shakarwal MK , Kumar A. , Jaju BP Effect of amitriptyline on blood glucose level in rabbits. Ind J Physiol Pharmacol 1995; 39: 279-282.

14.

Srorelein LH , Higson FM , Gleeson RN , Atrens DM Effect of chronic lithium, amitriptyline and mianserin on gluco-regulation, corticosterone and energy balance in the rats . Pharmacol Biochem Behav 1985; 22: 119-125.

15.

Pollak PT , Mukherjee SG , Frazer AD Sertraline induced hypoglycemia. Ann Pharmacother 2001; 35: 1371-1374.

16.

Ali A. , Ahmad FJ , Pillai KK , Vohora D. Evidence of the antiepileptic potential of amiloride with neuropharmacolgical benefits in some rodent models of epilepsy and behaviour. Epilepsy Behav 2004; 5: 523-530.

17.

Macdonald AD , Woolfe G. , Bergel F. , Morrison AL , Rinderknecht H. Analgesic action of pethidine derivatives and related compounds. Br J Pharmacol Chemother 1946; 1: 4-14.

18.

Trivelli LA , Ranney HM , Lai HT Hemoglobin components in patients with diabetes mellitus. New Engl J Med 1971; 284: 353-357.

19.

Gonen B. , Rubenstein AH , Rochman H. , Tanega SP , Horwitz DL Haemoglobin A1: an indicator of the metabolic control of diabetic patients . Lancet 1977; 2: 734-737.

20.

Morrow TJ Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protocols Neurosci 2004; 9: Unit 9.18.

21.

Khanam R. , Pillai KK Involvement of K+ channel in hypoglycemic effects of sertraline. Ind J Exp Biol 2006; 44: 120-122.

22.

Gupta BL , Nehal M. , Baquer NZ Effects of experimental diabetes on the activation of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages. Ind J Exp Biol 1997; 35: 792-797.

23.

Gomez R. , Huber J. , Lhullier F. , Barros HM Plasma insulin levels are increased by sertraline in rats under oral glucose overload. Braz J Med Biol Res 2001; 34: 1569-1572.

24.

Esser MJ , Sawynok J. Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects. Pain 1999; 80: 643-653.

25.

Ulugol A. , Karadag HC , Tamer M. , Firat Z. , Aslantas A. , Dokmeci I. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci Lett 2002; 328: 129-132.

26.

Kochar DK , Rawat N. , Agrawal RP , Vyas A. , Beniwal R. , Kochar SK , et al. Sodium valproate for painful diabetic neuropathy: a randomized double placebo controlled study. Quart J Med 2004; 97: 33-38.

27.

Ardid D. , Guilbaud G. Antinocieptive effects of acute and chronic injection of tricyclic antidepressants drugs in a new model of mono neuropathy in rats. Pain 1992; 49: 279-287.

28.

Carrie KJ , Brian JE , Anne BN , Harlan ES Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition. Neuropharmacology 2006; 51: 1172-1180.

29.

Harris CL , Olubusayo S. , Catherine A. , Angela M. , Sunny E. , Najam A. Pharmacology of serotonin receptor modulating electrically induced [3H] norepinephrine release from isolated mammalian iris ciliary bodies. J Ocular Pharmacol Ther 2002; 18: 339-348.